LEADER 01327nam  2200421   450 
001 9910159424803321
005 20180407083510.0
010   $a1-5361-0724-7
035   $a(CKB)3710000001019072
035   $a(MiAaPQ)EBC4789264
035   $a(EXLCZ)993710000001019072
100   $a20170206h20172017  uy|            0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aNeurofibromatosis (NF) $ediagnosis, management and health impact /$fJeremy Murphy, editor
210  1$aNew York :$cNova Biomedical,$d[2017]
210  4$dİ2017
215   $a1 online resource (120 pages) $cillustrations (some color)
225 1 $aNeurology - laboratory and clinical research developments
311   $a1-5361-0705-0 
320   $aIncludes bibliographical references and index.
410  0$aNeurology--laboratory and clinical research development series.
606   $aNeurofibromatosis
606   $aNeurofibromatosis$xDiagnosis
615  0$aNeurofibromatosis.
615  0$aNeurofibromatosis$xDiagnosis.
676   $a616.99/383
702   $aMurphy$b Jeremy
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910159424803321
996   $aNeurofibromatosis (NF)$92890995
997   $aUNINA